Showing results (201-210 of 343) with videos related to
Sort By:
Pageof 35
Gastroenterology|January 15, 2022
PUFA-Induced Metabolic Enteritis as a Fuel for Crohn's DiseaseJulian Schwärzler, Lisa Mayr, Arnau Vich Vila, et al.Gastroenterology|March 18, 2026
Identification of a druggable target that predicts postoperative Crohn's disease recurrenceSare Verstockt, Julian Schwärzler, Peter Willeit, et al.Hepatology (Baltimore, Md.)|April 12, 2011
Transcription factor Fra-1 induces cholangitis and liver fibrosisTrayana Kireva, Annette Erhardt, Gisa Tiegs, et al.Gut|June 16, 2022
Current therapies and new developments in NASHJean-François Dufour, Quentin M Anstee, Elisabetta Bugianesi, et al.Scandinavian Journal of Gastroenterology|July 9, 2008
Impaired counter-regulation of interleukin-1 by the soluble IL-1 receptor type II in patients with chronic liver diseaseOthmar Ludwiczek, Edouard Vannier, Alexander Moschen, et al.European Journal of Clinical Investigation|February 15, 2011
Effect of weight loss on serum pigment epithelium-derived factor levelsAlexander Tschoner, Wolfgang Sturm, Claudia Ress, et al.Journal of Hepatology|August 12, 2009
Effects of weight loss induced by bariatric surgery on hepatic adipocytokine expressionAlexander R Moschen, Clemens Molnar, Anna Maria Wolf, et al.American Journal of Physiology. Gastrointestinal and Liver Physiology|July 9, 2005
Role of nuclear receptors and hepatocyte-enriched transcription factors for Ntcp repression in biliary obstruction in mouse liverGernot Zollner, Martin Wagner, Peter Fickert, et al.BMJ Open Gastroenterology|July 16, 2020
Liver stiffness by transient elastography accompanies illness severity in COVID-19Maria Effenberger, Christoph Grander, Gernot Fritsche, et al.Plos One|December 2, 2016
Choice of High-Dose Intravenous Iron Preparation Determines Hypophosphatemia RiskBenedikt Schaefer, Philipp Würtinger, Armin Finkenstedt, et al.Pageof 35